Vertex Pharmaceuticals (VRTX) Tops Q3 Earnings and Revenue Estimates

Vertex Pharmaceuticals (VRTX) came out with quarterly earnings of $2.64 per share, beating the Zacks Consensus Estimate of $2.39 per share. This compares to earnings of $1.23 per share a year ago. These figures are adjusted for non-recurring items.